Patient-level meta-analysis comparing survival outcomes of TAVI vs. aortic valve replacement across different approaches: sternotomy and, innovatively, minimally invasive approach.

The COAPT study’s 5-year outcomes assess clinical parameters and mortality in patients with severe secondary mitral regurgitation (MR) after MitraClip implantation.

This study is a randomized, multicenter, prospective, open clinical trial comparing clinical outcomes 3 months after implanting an On-X mechanical mitral prosthesis in patients with standard anticoagulation ranges versus a lower target.

This is a multicenter, randomized clinical trial evaluating outcomes of transcatheter edge-to-edge tricuspid valve repair compared to optimized medical management in 350 patients with severe tricuspid regurgitation.

Analysis of post-procedure outcomes and mid-term follow-up of TAVI vs. SVA in a U.S. healthcare insurance database for patients with pure aortic insufficiency.

This retrospective American study evaluates short- and mid-term outcomes in a cohort of 56,331 patients with severe aortic stenosis and bicuspid aortic valve (BAV) undergoing conventional aortic valve replacement (AVR) or transcatheter implantation (TAVI).

Review article examining the boundaries of TAVI indication in favor of aortic valve replacement based on currently available evidence.

A comparative review of different non-transfemoral alternative access options for TAVI, with the objective of providing updated information on the latest techniques, outcomes, and advances in the field.

This nationwide retrospective study from Taiwan evaluates outcomes of biological versus mechanical mitral valve replacement in 1,576 patients.

This retrospective, multicenter study utilizes latent class analysis on 2321 patients undergoing surgery for primary mitral valve disease, aiming to identify phenotypes with distinct long-term prognoses.